Back
Newpark Resources 10K Form
Buy
55
NR
Newpark Resources
Last Price:
7.43
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | NR/Newpark Resources Quarterly |
2023-11-01 | 10Q | NR/Newpark Resources Quarterly |
2023-08-02 | 10Q | NR/Newpark Resources Quarterly |
2023-05-03 | 10Q | NR/Newpark Resources Quarterly |
2022-11-02 | 10Q | NR/Newpark Resources Quarterly |
2022-08-03 | 10Q | NR/Newpark Resources Quarterly |
Receive NR News And Ratings
See the #1 stock for the next 7 days that we like better than NR
NR Financial Statistics
Sales & Book Value
Annual Sales: | $749.6M |
---|---|
Cash Flow: | $-6.71M |
Price / Cash Flow: | 16.07 |
Annual Sales: | $3.66 |
Price / Book: | 1.98 |
Profitability
EPS (TTM): | -1.86000 |
---|---|
Net Income (TTM): | $-159.44M |
Gross Margin: | $138.54M |
Return on Equity: | -39.98% |
Return on Assets: | -26.94% |
Newpark Resources Earnings Forecast
Key Newpark Resources Financial Ratios
- The Gross Profit Margin over the past 35 years for NR is 18.48%.
- The Selling, General & Administrative Expenses for NR have been equal to 13.49% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 56.36% of Operating Income.
- The Net Earning history of NR is 1.94% of Total Revenues.
- Per Share Earnings over the last 35 years have been positive in 22 years.
Newpark Resources Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Energy Equipment & Services |
Sector: | Energy |
Current Symbol: | NR |
CUSIP: | 651718 |
Website: | newpark.com |
Debt
Debt-to-Equity Ratio: | 0.04 |
---|---|
Current Ratio: | 2.29 |
Quick Ratio: | 1.91 |
Price-to-Earnings
Trailing P/E Ratio: | 45.31 |
---|---|
Forward P/E Ratio: | 20.14 |
NR Technical Analysis vs Fundamental Analysis
Buy
55
Newpark Resources (NR)
is a Buy
Is Newpark Resources a Buy or a Sell?
-
Newpark Resources stock is rated a Buy
The current Newpark Resources [NR] share price is $7.25. The Score for NR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.